Virtu KCG Holdings’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$1.26M Sell
14,238
-28,000
-66% -$2.36M 0.04% 451
2017
Q1
$3.4M Sell
42,238
-74,326
-64% -$5.81M 0.09% 117
2016
Q4
$8.3M Buy
116,564
+93,836
+413% +$7.37M 0.2% 32
2016
Q3
$1.96M Sell
22,728
-36,410
-62% -$3.17M 0.05% 319
2016
Q2
$5.13M Buy
59,138
+8,849
+18% +$716K 0.11% 78
2016
Q1
$3.77M Buy
50,289
+16,227
+48% +$1.22M 0.11% 107
2015
Q4
$2.62M Buy
34,062
+5,300
+18% +$399K 0.04% 300
2015
Q3
$1.93M Sell
28,762
-21,474
-43% -$1.58M 0.03% 473
2015
Q2
$3.72M Buy
50,236
+30,818
+159% +$2.35M 0.07% 211
2015
Q1
$1.51M Sell
19,418
-44,264
-70% -$3.35M 0.03% 505
2014
Q4
$4.6M Sell
63,682
-32,942
-34% -$2.29M 0.08% 166
2014
Q3
$5.99M Buy
96,624
+70,889
+275% +$4.51M 0.12% 112
2014
Q2
$1.64M Buy
25,735
+9,977
+63% +$606K 0.03% 685
2014
Q1
$970K Sell
15,758
-29,123
-65% -$1.7M 0.01% 1263
2013
Q4
$2.58M Buy
44,881
+5,592
+14% +$317K 0.03% 499
2013
Q3
$2.09M Buy
+39,289
New +$2.11M 0.03% 604

Other funds holding MDT

Virtu KCG Holdings's MDT Position: Q2 2017 in Review

Virtu KCG Holdings reduced its Medtronic (MDT) stake by 66% in Q2 2017, selling an estimated $2.36M and leaving 14,238 shares worth $1.26M. The position accounts for 0.04% of the portfolio, ranked #451.

Virtu KCG Holdings first reported a position in MDT in Q3 2013 and has held it in 16 quarters since. The position peaked at $8.3M in Q4 2016. 1,280 funds tracked by Wall St. Rank hold MDT as of Q2 2017.

  • Virtu KCG Holdings held 14,238 shares of Medtronic worth $1.26M as of Q2 2017.
  • Virtu KCG Holdings sold 28,000 Medtronic shares in Q2 2017, an estimated $2.36M.
  • Medtronic made up 0.04% of Virtu KCG Holdings's portfolio in Q2 2017, its #451 holding.
  • Virtu KCG Holdings first reported a position in Medtronic in Q3 2013 and has held it in 16 quarters since.
  • Virtu KCG Holdings's Medtronic position peaked at $8.3M in Q4 2016.
  • 1,280 funds tracked by Wall St. Rank held Medtronic as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.